MedTrace Logo

Chiropractic Dosage for Lumbar Stenosis

NCT00527527 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-10-12

No results posted yet for this study

Summary

This randomized clinical trial pilot study will investigate the efficacy of different amounts of total treatment dosage over six weeks in 60 volunteer subjects with lumbar spinal stenosis. Subjects will be evenly randomized into four groups of either flexion distraction (FD) care or a control: Group 1 with 8 total FD treatment visits, Group 2 with 12 total FD treatment visits, Group 3 with 18 total FD treatment visits, or Group 4 with 8 total placebo control visits. The study is designed: (1) To determine the feasibility of a larger scale study in terms of logistics, recruitment efforts, and sample size estimations and (2) To determine among the three treatment groups the change in perceived pain levels and general functional health status at the end of six weeks of treatment and at three months post care as follow-up.

Conditions

  • Lumbar Spinal Stenosis

Interventions

PROCEDURE

flexion distraction

Chiropractic treatment using the flexion distraction apparatus

OTHER

placebo control

Placebo for comparison with flexion distraction treatment

Sponsors & Collaborators

  • Foundation for Chiropractic Education and Research (FCER)

    collaborator OTHER

  • National University of Health Sciences

    lead OTHER

Principal Investigators

  • Jerrilyn Cambron, DC, PhD · National University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00527527 on ClinicalTrials.gov